Live Quote · NASDAQCHRSHealthcare· Biotechnology

Coherus Oncology, Inc.

$0.37▼ 4.47%($-0.02)
MKT CAP $57.15MNEXT EARNINGS Mar 8, 2027
50%
Bullish
TickerSpark Score
41/100
▌ Weak
67
Valuation
40
Profitability
10
Growth
60
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CHRS research report →

Analyst Price Target
$6.02+1527.9% vs. today

Range $1.05 – $11

Analyst RatingBuy
14 Buy3 Hold0 Sell

Price Chart

-66.38% · this period
$2.51$1.44$0.37Nov 20May 26Nov 20
52-Week Range0% of range
Low
$0.36
Current
$0.37
High
$2.62